Conquering CHD

JULY 11, 2023

Blood Pressure Many medications used to treat congenital heart disease can affect blood pressure levels. It’s crucial to monitor your blood pressure regularly and report any significant changes to your healthcare provider so they can adjust the dosage of the medication accordingly.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease Blood Clot 52

Conquering CHD

JUNE 20, 2023

Blocking this enzyme helps relax blood vessels so there is a wider opening for better blood flow. This will lower blood pressure, making it easier for the heart to pump. POTENTIAL SIDE EFFECTS: Potential adverse reactions include coughing, dizziness, kidney problems, and low blood pressure.

Congenital Heart Disease 52

Congenital Heart Disease Congenital Heart Disease ACE Inhibitor 52

DAIC

MAY 16, 2024

Risk factors for PAD include smoking; having Type 1 or Type 2 diabetes, high blood pressure, high cholesterol, chronic kidney disease, atherosclerosis in other parts of the body (such as coronary artery disease); and being age 75 years or older. and Global Data From the American Heart Association. Black adults with PAD in the U.S.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Cardiometabolic Health Congress

JULY 17, 2024

Aprocitentan (Tryvio) Approved: March 20, 2024 Indication: Hypertension in adults Administration: Oral Mechanism: Endothelin A and B receptor antagonist Developer: Idorsia Pharmaceuticals Significance: First and only FDA-approved endothelin receptor antagonist for high blood pressure that remains uncontrolled with existing treatments.

Tricuspid 59

Tricuspid Open-Heart Surgery Kidney Disease Pediatrics 59